Results 51 to 60 of about 510,697 (405)

Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis [PDF]

, 2016
Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the outcome of therapy and of the development of comorbidities.
Cavaliere, Arturo, Palmery, Maura, Peluso, Ilaria   +2 more
core   +2 more sources

Genetic markers for psoriatic arthritis among patients with psoriasis. Part II: HLA genes [PDF]

Vestnik Dermatologii i Venerologii, 2021
Psoriatic arthritis often leads to the development of severe outcomes ankylosis, deformities of the affected joints with severe impairment of their functions and disability.
A. A. Kubanov, V. V. Chikin, A. E. Karamova, L. F. Znamenskaya, O. G. Artamonova, D. A. Verbenko   +5 more
doaj   +1 more source

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force [PDF]

, 2013
Background: Therapeutic targets have been defined for diseases like diabetes, hypertension or rheumatoid arthritis and adhering to them has improved outcomes. Such targets are just emerging for spondyloarthritis (SpA). Objective: To define the treatment
Baraliakos, Xenofon, Betteridge, Neil, Braun, Jürgen, Burgos-Vargas, Ruben, Collantes-Estevez, Eduardo, de Wit, Martinus, Deodhar, Atul, Dougados, Maxime, Elewaut, Dirk, Emery, Paul, FitzGerald, Oliver, Gossec, Laure, Helliwell, Philip, Jongkees, Merryn, Kavanaugh, Arthur, Kvien, Tore K, Landewé, Robert, Luger, Thomas, Maccarone, Mara, Mease, Philip, Olivieri, Ignazio, Redlich, Kurt, Reveille, John, Ritchlin, Christopher, Rudwaleit, Martin, Schoels, Monika, Sieper, Joachim, Smolen, Josef S, Van den Bosch, Filip, van der Heijde, Désirée, Wei, James Cheng-Chung, Winthrop, Kevin   +31 more
core   +2 more sources

Psoriatic Arthritis and Diabetes: A Population-Based Cross-Sectional Study

Dermatology Research and Practice, 2013
Background. Diabetes has been associated with psoriasis, but little is known about the association between psoriatic arthritis and diabetes. Methods. Patients diagnosed with psoriatic arthritis by a rheumatologist were compared to age- and sex-matched ...
Jacob Dreiher, Tamar Freud, Arnon D. Cohen   +2 more
doaj   +1 more source

TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents [PDF]

, 2017
BACKGROUND: Lymphocyte expansion and true lymphocytosis are commonly observed in the everyday clinical practice. The meaning of such phenomenon is often poorly understood so that discrimination between benign and malignant lymphocytosis remains ...
Amodeo, Rachele, Bove, Maurizio, Cox, Maria Christina, D'Amelio, Raffaele, DI ROSA, Roberta, Lagana', Bruno, Markovic, Milica, PICCHIANTI DIAMANTI, Andrea, Pilozzi, Emanuela, Rosado, Maria Manuela, Salemi, Simonetta, Sorgi, Maria Laura   +11 more
core   +1 more source

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Annals of the Rheumatic Diseases, 2020
Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or intolerance to at least one biologic disease-modifying ...
P. Mease, A. Lertratanakul, Jaclyn K Anderson, K. Papp, F. E. Van den Bosch, S. Tsuji, E. Dokoupilova, M. Keiserman, Xin Wang, S. Zhong, R. Mccaskill, P. Zueger, A. Pangan, W. Tillett   +13 more
semanticscholar   +1 more source

Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China

Acta Dermato-Venereologica, 2018
Genome-wide association studies have recently identified a number of non-major histocompatibility complex regions associated with psoriatic arthritis.
Qing Zhao, Yonghu Sun, Xi’an Fu, Zhenzhen Wang, Gongqi Yu, Zhenhua Yue, Yaru Wang, Huimin Zhang, Chuan Wang, Hong Liu, Qing Yang, Furen Zhang   +11 more
doaj   +1 more source

Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study [PDF]

, 2018
Background: Few studies have compared the efficacy of switching to adalimumab in the real-life setting in plaque psoriasis patients. Objective: To evaluate the effect of adalimumab in psoriasis patients previously treated with other biologics.
Armesto, Burmester, Carrera, Davison, Edson-Heredia, Elm, Gisondi, Gisondi, Gisondi, Gordon, Gossec, Gossec, Gottlieb, Griffiths, Gupta, Honda, Kurd, Lernia, Lernia, López-Ferrer, Lümig, Menter, Menter, Menter, Mrowietz, Nestle, Ortonne, Papoutsaki, Papp, Papp, Papp, Papp, Salvarani, Sbidian, Simone, Strober, Talamonti, Talamonti, Talamonti, Vandenbroucke, Vollenhoven   +40 more
core   +1 more source

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Annals of the Rheumatic Diseases
Objective New modes of action and more data on the efficacy and safety of existing drugs in psoriatic arthritis (PsA) required an update of the EULAR 2019 recommendations for the pharmacological treatment of PsA.
L. Gossec, A. Kerschbaumer, R. Ferreira, D. Aletaha, X. Baraliakos, H. Bertheussen, W-H. Boehncke, B. Esbensen, I. McInnes, Dennis McGonagle, Kevin L Winthrop, A. Bălănescu, Peter V. Balint, Gerd R. Burmester, Juan D Cañete, P. Claudepierre, L. Eder, M. Hetland, A. Iagnocco, L. E. Kristensen, R. Lories, R. Queiró, D. Mauro, H. Marzo-Ortega, P. Mease, Peter Nash, W. Wagenaar, Laura Savage, G. Schett, Stephanie J. W. Shoop‐Worrall, Yoshiya Tanaka, Filip E Van den Bosch, A. H. M. van der Helm-van Mil, A. Zabotti, D. van der Heijde, J. Smolen   +35 more
semanticscholar   +1 more source

Challenges in the Metabolomics-Based Biomarker Validation Pipeline

Metabolites
As end-products of the intersection between the genome and environmental influences, metabolites represent a promising approach to the discovery of novel biomarkers for diseases.
Shenghan Li, Nikita Looby, Vinod Chandran, Vathany Kulasingam   +3 more
doaj   +1 more source